Featured Story

BG Medicine slashes staff before launching automated version of heart failure test

BG Medicine is laying off more than half of its workforce as it gears up for the commercial launch of automated versions of its test for chronic heart failure.

George Washington University team developed a quick, hand-held portable Dx device

Researchers at George Washington University's School of Engineering and Applied Science said they've come up with a hand-held diagnostic device that would enable portable healthcare and quick testing.

ASCO: Provista's autoantibody/biomarker combo boosts breast cancer screening accuracy

Provista Diagnostics is celebrating some early clinical data that support its approach of using autoantibodies and serum protein biomarkers together to help differentiate between invasive breast cancer and benign breast conditions.

GE Healthcare, FBI allege Chinese engineer stole MRI trade secrets

Both GE Healthcare and the FBI are accusing a Chinese engineer of stealing millions of files of trade secrets from a maker of magnetic resonance imaging machines and related diagnostic equipment.

U.K. test may help Roche's cancer drug Avastin target ideal patients

Drugs such as Roche/Genentech's Avastin (bevacizumab) boost the survival odds of some ovarian cancer patients but not others. Researchers from The University of Manchester in the U.K. and colleagues believe they've developed a new blood test that can help find patients for whom the drug works best.


From Our Sister Sites

FiercePharma Manufacturing

Counterfeiters in Europe are displaying a fondness for mimicking high-priced Roche cancer drugs. For the second time in 5 months, authorities there have uncovered fakes, and the two cases appear not to be connected.


A growing buzz about potential safety issues has raised a cloud of doubt about Merck's osteoporosis drug odanacatib, which is likely to linger now that the pharma giant has released Phase III results and laid out plans for a delayed FDA filing.